Kindly MD Reports Financial Results for Second Quarter 2025
Kindly MD (NASDAQ:KDLY) reported its Q2 2025 financial results while preparing for a transformative merger with Nakamoto Holdings. The company received $9.2 million from warrant exercises and made its first Bitcoin purchase of 21 BTC valued at $2.25 million.
The merger, expected to close around August 11, 2025, has secured approximately $761.5 million in financing through PIPE investments ($561.5M) and convertible notes ($200M). However, Q2 revenues decreased by 36.1% to $408,527, while net loss widened to $2.41 million. Insurance reimbursements showed strong growth of 153.1% to $231,726.
The company ended Q2 with $6.02 million in cash, representing a 165% increase from December 2024.
Kindly MD (NASDAQ:KDLY) ha comunicato i risultati finanziari del secondo trimestre 2025 mentre si prepara a una fusione trasformativa con Nakamoto Holdings. L'azienda ha incassato 9,2 milioni di dollari dall'esercizio di warrant e ha effettuato il suo primo acquisto di Bitcoin, 21 BTC per un valore di 2,25 milioni di dollari.
La fusione, prevista per concludersi intorno all'11 agosto 2025, ha garantito circa 761,5 milioni di dollari di finanziamenti tramite investimenti PIPE (561,5 milioni) e note convertibili (200 milioni). Tuttavia, i ricavi del secondo trimestre sono diminuiti del 36,1% raggiungendo 408.527 dollari, mentre la perdita netta si 猫 ampliata a 2,41 milioni di dollari. I rimborsi assicurativi hanno mostrato una forte crescita del 153,1%, arrivando a 231.726 dollari.
L'azienda ha chiuso il secondo trimestre con 6,02 milioni di dollari in contanti, un aumento del 165% rispetto a dicembre 2024.
Kindly MD (NASDAQ:KDLY) report贸 sus resultados financieros del segundo trimestre de 2025 mientras se prepara para una fusi贸n transformadora con Nakamoto Holdings. La compa帽铆a recibi贸 9,2 millones de d贸lares por el ejercicio de warrants y realiz贸 su primera compra de Bitcoin, 21 BTC valorados en 2,25 millones de d贸lares.
La fusi贸n, que se espera cerrar alrededor del 11 de agosto de 2025, ha asegurado aproximadamente 761,5 millones de d贸lares en financiamiento a trav茅s de inversiones PIPE (561,5 millones) y notas convertibles (200 millones). Sin embargo, los ingresos del segundo trimestre disminuyeron un 36,1% hasta 408.527 d贸lares, mientras que la p茅rdida neta se ampli贸 a 2,41 millones de d贸lares. Los reembolsos de seguros mostraron un fuerte crecimiento del 153,1% hasta 231.726 d贸lares.
La compa帽铆a termin贸 el segundo trimestre con 6,02 millones de d贸lares en efectivo, lo que representa un aumento del 165% desde diciembre de 2024.
Kindly MD (NASDAQ:KDLY)電� Nakamoto Holdings鞕�鞚� 氤�順侅爜鞚� 頃╇硲鞚� 欷�牍勴晿氅� 2025雲� 2攵勱赴 鞛 鞁れ爜鞚� 氚滍憸頄堨姷雼堧嫟. 須岇偓電� 鞗岆煱韸� 頄夓偓搿滊秬韯� 920毵� 雼煬毳� 頇曤炒頄堦碃, 225毵� 雼煬 靸侂嫻鞚� 21 BTC毳� 觳� 牍勴姼旖旍澑 甑Г搿� 旮半頄堨姷雼堧嫟.
顷╇硲鞚赌 2025雲� 8鞗� 11鞚缄步 鞕勲霅� 鞓堨爼鞚措┌, PIPE 韴瀽(5鞏� 6,150毵� 雼煬)鞕� 鞝勴櫂靷眲(2鞏� 雼煬)毳� 韱淀暣 鞎� 7鞏� 6,150毵� 雼煬鞚� 鞛愱笀 臁半嫭鞚� 頇曤炒頄堨姷雼堧嫟. 攴鸽煬雮� 2攵勱赴 毵れ稖鞚� 36.1% 臧愳唽頃� 40毵� 8,527雼煬鞓�瓿�, 靾滌啇鞁れ潃 241毵� 雼煬搿� 頇曤寑霅橃棃鞀惦媹雼�. 氤错棙 頇橁笁鞚� 153.1% 歃濌皜頃� 23毵� 1,726雼煬毳� 旮半頄堨姷雼堧嫟.
須岇偓電� 2攵勱赴毳� 602毵� 雼煬鞚� 順勱笀鞙茧 毵堦皭頄堨溂氅�, 鞚措姅 2024雲� 12鞗� 雽�牍� 165% 歃濌皜頃� 靾橃箻鞛呺媹雼�.
Kindly MD (NASDAQ:KDLY) a publi茅 ses r茅sultats financiers du deuxi猫me trimestre 2025 tout en se pr茅parant 脿 une fusion transformative avec Nakamoto Holdings. La soci茅t茅 a re莽u 9,2 millions de dollars issus de l'exercice de bons de souscription et a effectu茅 son premier achat de Bitcoin, soit 21 BTC d'une valeur de 2,25 millions de dollars.
La fusion, pr茅vue pour se finaliser autour du 11 ao没t 2025, a s茅curis茅 environ 761,5 millions de dollars de financement gr芒ce 脿 des investissements PIPE (561,5 millions) et des billets convertibles (200 millions). Cependant, les revenus du deuxi猫me trimestre ont diminu茅 de 36,1 % 脿 408 527 dollars, tandis que la perte nette s'est creus茅e 脿 2,41 millions de dollars. Les remboursements d'assurance ont connu une forte croissance de 153,1 % 脿 231 726 dollars.
La soci茅t茅 a termin茅 le deuxi猫me trimestre avec 6,02 millions de dollars en liquidit茅s, soit une augmentation de 165 % par rapport 脿 d茅cembre 2024.
Kindly MD (NASDAQ:KDLY) meldete seine Finanzergebnisse f眉r das zweite Quartal 2025, w盲hrend das Unternehmen sich auf eine transformative Fusion mit Nakamoto Holdings vorbereitet. Das Unternehmen erhielt 9,2 Millionen US-Dollar aus der Aus眉bung von Warrants und t盲tigte seinen ersten Bitcoin-Kauf von 21 BTC im Wert von 2,25 Millionen US-Dollar.
Die Fusion, die voraussichtlich um den 11. August 2025 abgeschlossen wird, sicherte etwa 761,5 Millionen US-Dollar an Finanzierung durch PIPE-Investitionen (561,5 Mio.) und Wandelanleihen (200 Mio.). Die Einnahmen im zweiten Quartal sanken jedoch um 36,1 % auf 408.527 US-Dollar, w盲hrend der Nettoverlust auf 2,41 Millionen US-Dollar anwuchs. Die Versicherungsr眉ckerstattungen verzeichneten ein starkes Wachstum von 153,1 % auf 231.726 US-Dollar.
Das Unternehmen beendete das zweite Quartal mit 6,02 Millionen US-Dollar in bar, was einem Anstieg von 165 % gegen眉ber Dezember 2024 entspricht.
- Secured $761.5 million in total financing for the Nakamoto merger
- Insurance reimbursements increased 153.1% year-over-year to $231,726
- Cash position strengthened by 165% to $6.02 million
- Received $9.2 million from warrant exercises
- Successfully initiated Bitcoin strategy with purchase of 21 BTC
- Revenue decreased 36.1% year-over-year to $408,527
- Net loss widened to $2.41 million from $1.32 million year-over-year
- Closure of Bountiful location impacting revenue
- Decrease in cash-pay patient care service pricing affecting top line
Insights
Kindly MD's Q2 shows widening losses and revenue decline despite securing $761.5M through pending Nakamoto merger, pivoting toward Bitcoin acquisition strategy.
The Q2 2025 results for Kindly MD reveal a company in transition, with revenues declining 36.1% year-over-year to
What's most notable is Kindly MD's strategic pivot. The company has begun purchasing Bitcoin (21 BTC valued at
While insurance reimbursements increased by
Proposed merger with Nakamoto Holdings expected to close on approximately August 11, 2025
During the quarter, Kindly MD made initial purchase of 21 BTC valued at
Cash and cash equivalents was
SALT LAKE CITY, UTAH / / August 5, 2025 / Kindly MD, Inc. (NASDAQ:NAKA) ("KindlyMD"), a leading provider of integrated healthcare services, today announced its financial results for the second quarter ended June 30, 2025.
Tim Pickett, Founder and CEO of KindlyMD, commented, "During the quarter we received approximately
Kindly MD and Nakamoto Operational Highlights
On May 12, 2025, Kindly MD entered into a definitive Agreement and Plan of Merger (the "Merger Agreement") with Nakamoto Holdings, Inc. ("Nakamoto") with plans post-closing to establish a Bitcoin treasury. To date, the Company has entered into subscription agreements totaling over
On May 18, 2025, holders of a majority of the outstanding common stock of KindlyMD delivered a written consent approving the Merger Agreement and related transactions with Nakamoto.
Subsequent to the quarter, on July 22, 2025, KindlyMD and Nakamoto announced the filing of the definitive information statement in connection with the proposed Merger with the U.S. Securities and Exchange Commission ("SEC"). KindlyMD and Nakamoto expect to close the transaction on or around August 11, 2025, subject to other customary closing conditions.
Kindly MD Financial Highlights for the Second Quarter Ending June 30, 2025
Kindly MD earned
Revenues decreased by
Net loss was
Net cash used in investing activities was
As a result of these cash flow activities, net cash increased by
About KindlyMD
KindlyMD庐 is a patient-first healthcare company integrating traditional primary care, pain management, behavioral health, and alternative therapies to provide comprehensive, whole-person care. In May 2025, KindlyMD announced a definitive merger agreement with Nakamoto Holdings, a Bitcoin-native holding company, to establish a publicly traded Bitcoin treasury vehicle. This strategic partnership aims to combine KindlyMD's healthcare expertise with Nakamoto's vision of integrating Bitcoin into global capital markets, creating a diversified entity focused on both healthcare innovation and Bitcoin treasury management.
Its specialty outpatient clinical services are reimbursed by Medicare, Medicaid, and commercial insurance contracts as well as offered on a fee-for-service basis. For more information, please visit .
About Nakamoto
Nakamoto is a Bitcoin treasury company building a global portfolio of Bitcoin-native companies. Nakamoto plans to establish the first publicly traded conglomerate of Bitcoin companies by accumulating Bitcoin in its treasury and by leveraging its treasury to acquire and develop an ecosystem of Bitcoin companies across finance, media, advisory and more. The company aims to provide commercial and financial infrastructure for the next generation of capital markets. For more information, please visit .
Forward-Looking Statements
All statements, other than statements of historical fact, included in this release that address activities, events or developments that Kindly MD or Nakamoto expects, believes or anticipates will or may occur in the future are forward-looking statements. Words such as "estimate," "project," "predict," "believe," "expect," "anticipate," "potential," "create," "intend," "could," "would," "may," "plan," "will," "guidance," "look," "goal," "future," "build," "focus," "continue," "strive," "allow" or the negative of such terms or other variations thereof and words and terms of similar substance used in connection with any discussion of future plans, actions, or events identify forward-looking statements. However, the absence of these words does not mean that the statements are not forward-looking. These forward-looking statements include, but are not limited to, statements regarding the proposed merger and related transactions, (collectively, the "Transactions") the expected closing of the proposed Transactions and the timing thereof and as adjusted descriptions of the post-transaction company and its operations, strategies and plans, integration, debt levels and leverage ratio, capital expenditures, cash flows and anticipated uses thereof, synergies, opportunities and anticipated future performance, including the management team and board of directors of the combined company and expected use of proceeds from the Transactions, and any post-closing transactions contemplated between the combined company and BTC Inc (and/or UTXO, LLC through BTC Inc). Information adjusted for the proposed Transactions should not be considered a forecast of future results. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements included in this release. These include the risk that Kindly MD and Nakamoto businesses (which may include the businesses of BTC Inc and/or UTXO in the future, as applicable) will not be integrated successfully and the risk that Kindly MD or the applicable governing bodies of BTC Inc and/or UTXO may not pursue or approve the terms of an acquisition of BTC Inc and/or UTXO; the risk that cost savings, synergies and growth from the proposed transaction may not be fully realized or may take longer to realize than expected; the possibility that shareholders of Kindly MD may not approve the issuance of new shares of Kindly MD common stock in the Transactions or that shareholders of Kindly MD may not approve the Transactions; the risk that a condition to closing of the Transactions may not be satisfied, that either party may terminate the merger agreement, the subscription agreements of the convertible debt purchase agreement or that the closing of the Transactions might be delayed or not occur at all; potential adverse reactions or changes to business or employee relationships, including those resulting from the announcement or completion of the Transactions; the parties do not receive regulatory approval of the Transactions; the occurrence of any other event, change, or other circumstances that could give rise to the termination of the merger agreement relating to the Transactions; the risk that changes in Kindly MD's capital structure and governance could have adverse effects on the market value of its securities; the ability of Kindly MD and Nakamoto to retain customers and retain and hire key personnel and maintain relationships with their suppliers and customers and on Kindly MD and Nakamoto's operating results and business generally; the risk the Transactions could distract management from ongoing business operations or cause Kindly MD and/or Nakamoto to incur substantial costs; the risk that Kindly MD may be unable to reduce expenses or access financing or liquidity; the impact of any related economic downturn; the risk of changes in governmental regulations or enforcement practices; and other important factors that could cause actual results to differ materially from those projected. All such factors are difficult to predict and are beyond Kindly MD's and Nakamoto's control, including those detailed in Kindly MD's Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and such other documents of Kindly MD filed, or to be filed, with the SEC that are or will be available on Kindly MD's website at and on the website of the SEC at www.sec.gov. All forward-looking statements are based on assumptions that Kindly MD and Nakamoto believe to be reasonable but that may not prove to be accurate. Any forward-looking statement speaks only as of the date on which such statement is made, and neither Kindly MD or Nakamoto undertakes any obligation to correct or update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by applicable law. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.
Media Contacts
Valter Pinto, Managing Director
KCSA Strategic Communications
(212) 896-1254
[email protected]
KINDLY MD, INC.
CONDENSED BALANCE SHEETS
June 30, 2025 | December 31, 2024 | |||||||
(Unaudited) | ||||||||
ASSETS | ||||||||
Current Assets | ||||||||
Cash and cash equivalents | $ | 6,024,604 | $ | 2,273,624 | ||||
Accounts receivable, net | 7,472 | 36,850 | ||||||
Inventories, net | 1,078 | 4,300 | ||||||
Prepaid expenses and other current assets | 339,100 | 190,878 | ||||||
Total Current Assets | 6,372,254 | 2,505,652 | ||||||
Digital assets | 2,250,566 | - | ||||||
Property and equipment, net | 84,058 | 122,955 | ||||||
Capitalized software | 619,861 | 388,338 | ||||||
Operating lease right-of-use assets | 545,422 | 641,651 | ||||||
Security deposits | 18,121 | 19,396 | ||||||
TOTAL ASSETS | $ | 9,890,282 | $ | 3,677,992 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
Current Liabilities | ||||||||
Accounts payable and accrued expenses | $ | 364,201 | $ | 323,725 | ||||
Customer deposits | 175 | 2,275 | ||||||
Current portion of operating lease liabilities | 126,040 | 138,743 | ||||||
Current portion of finance lease liabilities | - | 2,030 | ||||||
Current portion of notes payable, net | - | 139,277 | ||||||
Total Current Liabilities | 490,416 | 606,050 | ||||||
Operating lease liabilities, net of current portion | 432,978 | 496,017 | ||||||
Finance lease liabilities, net of current portion | - | 7,615 | ||||||
TOTAL LIABILITIES | 923,394 | 1,109,682 | ||||||
Stockholders' Equity | ||||||||
Preferred Stock, | - | - | ||||||
Common stock, | 7,576 | 6,050 | ||||||
Treasury stock, at cost; 0 and 20,500 shares as of June 30, 2025 and December 31, 2024, respectively | - | (22,145 | ) | |||||
Additional paid-in capital | 20,186,811 | 10,360,106 | ||||||
Accumulated deficit | (11,227,499 | ) | (7,775,701 | ) | ||||
TOTAL STOCKHOLDERS' EQUITY | 8,966,888 | 2,568,310 | ||||||
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ | 9,890,282 | $ | 3,677,992 | ||||
KINDLY MD, INC.
CONDENSED STATEMENTS OF OPERATIONS
(UNAUDITED)
2025 | 2024 | 2025 | 2024 | |||||||||||||
For the Three Months Ended June 30, | For the Six Months Ended June 30, | |||||||||||||||
2025 | 2024 | 2025 | 2024 | |||||||||||||
Net revenues | $ | 408,527 | $ | 639,057 | $ | 988,182 | $ | 1,468,086 | ||||||||
Operating Expenses | ||||||||||||||||
Cost of revenues | 7,552 | 61,947 | 15,466 | 69,691 | ||||||||||||
Salaries and wages | 1,656,288 | 802,287 | 2,659,465 | 1,510,253 | ||||||||||||
General and administrative | 1,121,482 | 443,969 | 1,713,919 | 734,097 | ||||||||||||
Research and development | 4 | 342,314 | 101 | 377,731 | ||||||||||||
Depreciation | 14,692 | 25,733 | 32,463 | 50,634 | ||||||||||||
Total Operating Expenses | 2,800,018 | 1,676,250 | 4,421,414 | 2,742,406 | ||||||||||||
LOSS FROM OPERATIONS | (2,391,491 | ) | (1,037,193 | ) | (3,433,232 | ) | (1,274,320 | ) | ||||||||
Other Income (Expense) | ||||||||||||||||
Other income | 26,825 | 13,828 | 36,885 | 25,868 | ||||||||||||
Interest expense | (3,668 | ) | (318,450 | ) | (9,998 | ) | (375,689 | ) | ||||||||
Unrealized loss on digital assets | (39,019 | ) | - | (39,019 | ) | - | ||||||||||
Loss on disposal of property and equipment | (6,434 | ) | - | (6,434 | ) | - | ||||||||||
Loss on extinguishment of debt | - | (38,889 | ) | - | (38,889 | ) | ||||||||||
Gain on change in fair value of derivative liabilities | - | 61,051 | - | 61,051 | ||||||||||||
Total Other Expense | (22,296 | ) | (282,460 | ) | (18,566 | ) | (327,659 | ) | ||||||||
NET LOSS BEFORE INCOME TAXES | (2,413,787 | ) | (1,319,653 | ) | (3,451,798 | ) | (1,601,979 | ) | ||||||||
Provision for income taxes | - | - | - | - | ||||||||||||
NET LOSS | $ | (2,413,787 | ) | $ | (1,319,653 | ) | $ | (3,451,798 | ) | $ | (1,601,979 | ) | ||||
LOSS PER COMMON SHARE - BASIC AND DILUTED | $ | (0.35 | ) | $ | (0.26 | ) | $ | (0.54 | ) | $ | (0.33 | ) | ||||
WEIGHTED-AVERAGE NUMBER OF SHARES OUTSTANDING - BASIC AND DILUTED | 6,817,584 | 5,009,956 | 6,421,263 | 4,813,877 | ||||||||||||
KINDLY MD, INC.
CONDENSED STATEMENTS OF CASH FLOWS
(UNAUDITED)
2025 | 2024 | |||||||
For the Six Months Ended June 30, | ||||||||
2025 | 2024 | |||||||
CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
Net loss | $ | (3,451,798 | ) | $ | (1,601,979 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Stock-based compensation | 575,350 | 15,500 | ||||||
Issuance of common stock for compensation | 45,760 | - | ||||||
Issuance of common stock for services | 22,403 | - | ||||||
Depreciation expense | 32,463 | 50,634 | ||||||
Bad debt expense | 8,948 | - | ||||||
Unrealized loss on digital assets | 39,019 | - | ||||||
Loss on disposal of property and equipment | 6,434 | - | ||||||
Loss on extinguishment of debt | - | 38,889 | ||||||
Gain on change in fair value of derivative liabilities | - | (61,051 | ) | |||||
Amortization of debt discounts | 9,551 | 357,439 | ||||||
Amortization of right-of-use assets | 96,229 | 51,529 | ||||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable | 20,430 | 22,819 | ||||||
Inventories | 3,222 | 59,377 | ||||||
Prepaid expenses and other current assets | (148,222 | ) | (305,430 | ) | ||||
Security deposits | 1,275 | - | ||||||
Accounts payable and accrued expenses | 40,476 | 298,939 | ||||||
Customer deposits | (2,100 | ) | 725 | |||||
Operating lease liabilities | (75,742 | ) | (54,367 | ) | ||||
Net cash used in operating activities | (2,776,302 | ) | (1,126,976 | ) | ||||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
Purchases of digital assets | (2,289,585 | ) | - | |||||
Purchases of property and equipment | - | (11,182 | ) | |||||
Capitalized software additions | (231,523 | ) | - | |||||
Net cash used in investing activities | (2,521,108 | ) | (11,182 | ) | ||||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
Net proceeds from issuance of notes payable | - | 45,000 | ||||||
Net proceeds from issuance of common stock and warrants in connection with a public offering | - | 5,860,650 | ||||||
Proceeds from exercise of warrants | 9,216,420 | - | ||||||
Repurchase of treasury stock | (9,557 | ) | - | |||||
Repayments of notes payable | (148,828 | ) | (552,655 | ) | ||||
Repayments of finance lease liabilities | (9,645 | ) | (331 | ) | ||||
Net cash provided by financing activities | 9,048,390 | 5,352,664 | ||||||
NET CHANGE IN CASH AND CASH EQUIVALENTS | 3,750,980 | 4,214,506 | ||||||
CASH AND CASH EQUIVALENTS | ||||||||
Beginning of the period | 2,273,624 | 525,500 | ||||||
End of the period | $ | 6,024,604 | $ | 4,740,006 | ||||
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION | ||||||||
Cash paid for interest | $ | 455 | $ | 19,089 | ||||
Cash paid for income taxes | $ | - | $ | - | ||||
NON-CASH INVESTING AND FINANCING ACTIVITIES | ||||||||
Retirement of treasury stock | $ | 31,702 | $ | - | ||||
Cashless exercise of warrants | $ | 55 | $ | - | ||||
Debt discounts on notes payable | $ | - | $ | 10,556 | ||||
Fair value of derivative liabilities recognized upon issuance of notes payable | $ | - | $ | 38,000 | ||||
Extinguishment of derivative liabilities upon settlement of notes payable | $ | - | $ | 214,949 | ||||
Financed purchases of property and equipment | $ | - | $ | 10,976 | ||||
SOURCE: KindlyMD, Inc
View the original on ACCESS Newswire
FAQ
What are the key terms of Kindly MD's merger with Nakamoto Holdings?
How much Bitcoin does Kindly MD (KDLY) currently hold?
What was Kindly MD's (KDLY) revenue in Q2 2025?
How much cash does Kindly MD (KDLY) have as of Q2 2025?
What caused Kindly MD's revenue decline in Q2 2025?
